Advertisement
Screener

Heartflow, Inc. (HTFL) Operating Lease, Right-of-Use Asset, Amortization Expense

Heartflow, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense

Heartflow, Inc. (HTFL) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $2.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-13

  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.04M, a 39.44% increase year-over-year.
  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.01M, a 39.64% increase year-over-year.
  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $875.00K, a 24.64% increase year-over-year.
  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $786.00K, a 14.91% increase year-over-year.
  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $3.13M, a 14.55% increase from fiscal 2024.
  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $2.73M, a 5.33% decline from fiscal 2023.
  • Heartflow, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $2.89M.
Period endOperating Lease, Right-of-Use Asset, Amortization Expense 3 monthOperating Lease, Right-of-Use Asset, Amortization Expense 6 monthOperating Lease, Right-of-Use Asset, Amortization Expense 9 monthOperating Lease, Right-of-Use Asset, Amortization Expense 12 month
2026-06-30$1.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$2.05M
10-Q · filed 2026-08-13
$2.93M
derived: sum of 3 quarters · filed 2026-08-13
$3.71M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$1.01M
10-Q · filed 2026-05-14
$1.89M
derived: sum of 2 quarters · filed 2026-05-14
$2.67M
derived: sum of 3 quarters · filed 2026-05-14
$3.42M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$875.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$1.66M
derived: sum of 2 quarters · filed 2026-03-18
$2.41M
derived: sum of 3 quarters · filed 2026-08-13
$3.13M
10-K · filed 2026-03-18
2025-09-30$786.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$1.53M
derived: sum of 2 quarters · filed 2026-08-13
$2.26M
10-Q · filed 2025-11-12
$2.96M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$748.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$1.47M
10-Q · filed 2026-08-13
$2.17M
derived: sum of 3 quarters · filed 2026-08-13
$2.86M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$724.00K
10-Q · filed 2026-05-14
$1.43M
derived: sum of 2 quarters · filed 2026-05-14
$2.11M
derived: sum of 3 quarters · filed 2026-05-14
2024-12-31$702.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$1.39M
derived: sum of 2 quarters · filed 2026-03-18
$2.73M
10-K · filed 2026-03-18
2024-09-30$684.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$2.03M
10-Q · filed 2025-11-12
2024-06-30$1.35M
10-Q · filed 2025-09-19
2023-12-31$2.89M
10-K · filed 2026-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55